Clinical trial
A Phase 2b Diabetic Kidney Disease Study
NCT04170543
Study timeline
Study start (actual)2019-11-18Date precision: day
Registry last updated2024-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Kidney Diseaseunresolved
Interventions
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
SantiagoChile4San AntonioTexas, United States3Buenos AiresArgentina3HoustonTexas, United States2ChicagoIllinois, United States2OsakaJapan2AtlantaGeorgia, United States1MiamiFlorida, United States1TorontoOntario, Canada1SeoulSouth Korea1BirminghamAlabama, United States1San DiegoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04170543 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.